Disorders of the Eye

Avery's Diseases of the Newborn

Volumn , Issue , 2005, Pages 1539-1555

  Madan, Ashima ^a,b   Good, William V ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^c SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34347332609     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072169347-7.50103-7     Document Type: Chapter

References (218)

1. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450.
2. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996, 114:66-71.
3. Ahn JC, Hoyt WF, Hoyt CS Tonic upgaze in infancy. A report of three cases. Arch Ophthalmol 1989, 107:57-58.
4. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 1995, 92:10457-10461.
5. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995, 1:1024-1028.
6. Andersen CC, Phelps DL Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev(2) 2000, CD001693, Review.
7. Andrews A, Balciunaite E, Leong FL, et al. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1999, 40:2683-2689.
8. Aranda JV, Clark TE, Maniello R, et al. Blood transfusion: Possible potentiating risk factor in retrolental fibroplasias. Pediatr Res 1975, 9:362.
9. Archer SM, Sondhi N, Helveston EM Strabismus in infancy. Ophthalmology 1989, 96:133-137.
10. Arnoldi KA, Tychsen L Prevalence of intracranial lesions in children initially diagnosed with disconjugate nystagmus (spasmus nutans). J Pediatr Ophthalmol Strabismus 1995, 32:296-301.
11. Ashton N Animal experiments in retrolental fibroplasias. Trans Am Acad Ophthalmol Otolaryngeal 1954, 58:51-54.
12. Ashton N Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The XX Francis I. Proctor Lecture. Am J Ophthalmol 1966, 62:412-435.
13. Ashton N Retinal angiogenesis in the human embryo. Br Med Bull 1970, 26:103-106.
14. Askie LM, Henderson-Smart DJ Early versus late discontinuation of oxygen in preterm or low birth weight infants. Cochrane Database Syst Rev 2 2000.
15. Askie LM, Henderson-Smart DJ Gradual versus abrupt discontinuation of oxygen in preterm or low birth weight infants. Cochrane Database Syst Rev 4 2001.
16. Asrani S, Freedman S, Hasselblad V, et al. Does primary intraocular lens implantation prevent "aphakic" glaucoma in children?. J Aapos 2000, 4:33-39.
17. Ausprunk DH, Folkman J Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977, 14:53-65.
18. Avery ME, Oppenheimer EH Recent increase in mortality from hyaline membrane disease. J Pediatr 1960, 57:553-559.
19. Bancalari E, Flynn J, Goldberg RN, et al. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 1987, 79:663-669.
20. 2 and retrolental fibroplasia (RLF). Pediatr Res 1981, 15:649.
21. Bedrossian RH, Carmichael P, Ritter J Effects of oxygen weaning in retrolental fibroplasias. Arch Ophthalmol 1955, 53:514-518.
22. Biglan AW, Brown DR, Reynolds JD, et al. Risk factors associated with retrolental fibroplasia. Ophthalmology 1984, 91:1504-1511.
23. Birch EE, Stager D, Leffler J, Weakley D Early treatment of congenital unilateral cataract minimizes unequal competition. Invest Ophthalmol Vis Sci 1998, 39:1560-1566.
24. Birch EE, Stager DR The critical period for surgical treatment of dense congenital unilateral cataract. Invest Ophthalmol Vis Sci 1996, 37:1532-1538.
25. Blumenfeld LC, Siatkowski RM, Johnson RA, et al. Retinopathy of prematurity in multiple-gestation pregnancies. Am J Ophthalmol 1998, 125:197-203.
26. Brockhurst RJ, Chishti MI Cicatricial retrolental fibroplasia: Its occurrence without oxygen administration and in full term infants. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975, 195:113-128.
27. Brooks SE, Gu X, Samuel S, et al. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest Ophthalmol Vis Sci 2001, 42:222-228.
28. Brooks SE, Marcus DM, Gillis D, et al. The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study. Pediatrics 1999, 104:514-518.
29. Brown BA, Thach AB, Song JC, et al. Retinopathy of prematurity: Evaluation of risk factors. Int Ophthalmol 1998, 22:279-283.
30. Brown DR, Milley JR, Ripepi UJ, et al. Retinopathy of prematurity: Risk factors in a five-year cohort of critically ill premature neonates. Am J Dis Child 1987, 141:154-160.
31. Bullard SR, Donahue SP, Feman SS, et al. The decreasing incidence and severity of retinopathy of prematurity. J Aapos 1999, 3:46-52.
32. Caddell JL Hypothesis: The possible role of magnesium and copper deficiency in retinopathy of prematurity. Magnes Res 1995, 8:261-270.
33. Campbell K Intensive oxygen therapy as a possible cause of retrolental fibroplasias: A clinical approach. Med J Aust 1951, 2:48-54.
34. Chandler JW Controversies in ocular prophylaxis of newborns. Arch Ophthalmol 1989, 107:814-815.
35. Chan-Ling T, Gock B, Stone J The effect of oxygen on vasoformative cell division: Evidence that "physiological hypoxia" is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 1995, 36:1201-1214.
36. Chan-Ling T, Stone J Retinopathy of prematurity: Origins in the architecture of the retina. Prog Retinal Res 1993, 12:155-177.
37. Chan-Ling TL, Halasz P, Stone J Development of retinal vasculature in the cat: Processes and mechanisms. Curr Eye Res 1990, 9:459-478.
38. Chattha AS, Delong GR Sylvian aqueduct syndrome as a sign of acute obstructive hydrocephalus in children. J Neurol Neurosurg Psychiatry 1975, 38:288-296.
39. Chow LC, Wright KW, Sola A CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy in extremely low birth weight infants?. Pediatrics III 2003, 339-345.
40. Chuang YC, Yang CM Scleral buckling for stage 4 retinopathy of prematurity. Ophthalmic Surg Lasers 2000, 31:374-379.
41. Clark C, Gibbs JA, Maniello R, et al. Blood transfusion: A possible risk factor in retrolental fibroplasia. Acta Paediatr Scand 1981, 70:537-539.
42. Coats DK, Paysse EA, Steinkuller PG Threshold retinopathy of prematurity in neonates less than 25 weeks' estimated gestational age. J Aapos 2000, 4:183-185.
43. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984, 102:1130-1134. Committee for the Classification of Retinopathy of Prematurity.
44. Vitamin E and the prevention of retinopathy of prematurity. Pediatrics 1985, 76:315-316. Committee on Fetus and Newborn.
45. Connolly BP, McNamara JA, Sharma S, et al. A comparison of laser photocoagulation with transscleral cryotherapy in the treatment of threshold retinopathy of prematurity. Ophthalmology 1998, 105:1628-1631.
46. Cooke RW, Clark D, Hickey-Dwyer M, et al. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr 1993, 152:833-836.
47. Cross KW Cost of preventing retrolental fibroplasia?. Lancet 1973, 2:954-956.
48. Multicenter trial of cryotherapy for retinopathy of prematurity: Preliminary results. Arch Ophthalmol 1988, 106:471-479. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
49. Multicenter of cryotherapy for retinopathy of prematurity: One year outcome structure and function. Arch Ophthalmol 1990, 108:1408-1416. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
50. Multicenter trial of cryotherapy for retinopathy of prematurity: Snellen visual acuity and structural outcome at 51/2 years after randomization. Arch Ophthalmol 1996, 114:417-424. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
51. The natural ocular outcome of premature birth and retinopathy: Status at 1 year. Arch Ophthalmol 1994, 112:903-912. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
52. Ophthalmological outcomes at 10 years. Arch Ophthalmol 2001, 119:1110-1118. Cryotherapy for Retinopathy of Prematurity Multicenter Trial.
53. Cunningham S, McColm JR, Wade J, et al. A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. Invest Ophthalmol Vis Sci 2000, 41:4275-4280.
54. D'Amore PA Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci 1994, 35:3974-3979.
55. Dannevig L, Straume B, Melby K Ophthalmia neonatorum in northern Norway. II. Microbiology with emphasis on Chlamydia trachomatis. Acta Ophthalmol (Copenh) 1992, 70:19-25.
56. D'Arcangelo D, Facchiano F, Barlucchi LM, et al. Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. Circ Res 2000, 86:312-318.
57. DeJonge MH, Khuntia A, Maisels MJ, et al. Bilirubin levels and severe retinopathy of prematurity in infants with estimated gestational ages of 23 to 26 weeks. J Pediatr 1999, 135:102-104.
58. Deonna T, Roulet E, Meyer HV Benign paroxysmal tonic upgaze of childhood a new syndrome. Neuropediatrics 1990, 21:213-214.
59. Dollery CT, Bulpitt CJ, Kohner EM Oxygen supply to the retina from the retinal and choroidal circulations at normal and increased arterial oxygen tensions. Invest Ophthalmol 1969, 8:588-594.
60. Dreher B, Robinson SR Development of the retinofugal pathway in birds and mammals: Evidence for a common "timetable". Brain Behav Evol 1988, 31:369-390.
61. Ellsworth RM The practical management of retinoblastoma. Trans Am Ophthalmol Soc 1969, 67:462-534.
62. Fielding DW, Fryer AE Recurrence of orbital cysts in the branchio-oculo-facial syndrome. J Med Genet 1992, 29:430-431.
63. Finer NN, Peters KL, Hayek Z, et al. Vitamin E and necrotizing enterocolitis. Pediatrics 1984, 73:387-393.
64. Flynn JT, Bancalari E, Bawol R, et al. Retinopathy of prematurity: A randomized, prospective trial of transcutaneous oxygen monitoring. Ophthalmology 1987, 94:630-638.
65. Folkman J Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995, 333:1757-1763.
66. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996, 16:4604-4613.
67. Gallie BL, Dunn JM, Hamel PA, et al. How do retinoblastoma tumours form?. Eye 1992, 6:226-231.
68. Gallo JE, Jacobson L, Broberger U Perinatal factors associated with retinopathy of prematurity. Acta Paediatr 1993, 82:829-834.
69. Gariano RF, Iruela-Arispe ML, Hendrickson AE Vascular development in primate retina: Comparison of laminar plexus formation in monkey and human. Invest Ophthalmol Vis Sci 1994, 35:3442-3455.
70. Gaynon MW, Stevenson DK, Sunshine P, et al. Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity. J Perinatol 1997, 17:434-438.
71. Gelbart SS, Hoyt CS, Jastrebski G, et al. Long-term visual results in bilateral congenital cataracts. Am J Ophthalmol 1982, 93:615-621.
72. Gilbert CE, Anderton L, Dandona L, et al. Prevalence of visual impairment in children: A review of available data. Ophthalmic Epidemiol 1999, 6:73-82.
73. Gittinger JW To image or not to image. Surv Ophthalmol 1988, 32:350-356.
74. Glass P, Avery GB, Subramanian KN, et al. Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity. N Engl J Med 1985, 313:401-404.
75. Good WV, Barkovich AJ, Nickel BL, et al. Bilateral congenital oculomotor nerve palsy in a child with brain anomalies. Am J Ophthalmol 1991, 111:555-558.
76. Good WV, Crain LS, Quint RD, et al. Overlooking: A sign of bilateral central scotomata in children. Dev Med Child Neurol 1992, 34:69-73.
77. Good W, Hou C, Carden SM Transient, idiopathic nystagmus in infants. Dev Med ChildNeurol 2003, 45:304-307.
78. Good WV, Hoyt CS Behavioral correlates of poor vision in children. Int Ophthalmol Clin 1989, 29:57-60.
79. Good WV, Jan JE, De Sa L, et al. Cortical visual impairment in children. Surv Ophthalmol 1994, 38:351-364.
80. Good WV, Jan JE, Hoyt CS, et al. Monocular vision loss can cause bilateral nystagmus in young children. Dev Med Child Neurol 1997, 39:421-424.
81. Good WV, Jan JE, Burden SK, et al. Recent advances in cortical visual impairment. Dev MedChild Neurol 2001, 43:56-60.
82. Good WV, Koch TS, Jan JE Monocular nystagmus caused by unilateral anterior visual-pathway disease. Dev Med Child Neurol 1993, 35:1106-1110.
83. Gross JL, Moscatelli D, Jaffe EA, et al. Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol 1982, 95:974-981.
84. Gunn TR, Easdown J, Outerbridge EW, et al. Risk factors in retrolental fibroplasia. Pediatrics 1980, 65:1096-1100.
85. Guy LP, Lanman JT, Dancis J The possibility of total elimination of retrolental fibroplasias by oxygen restriction. Pediatrics 1956, 17:247-251.
86. Hack M, Friedman H, Fanaroff AA Outcomes of extremely low birth weight infants. Pediatrics 1996, 98:931-937.
87. Hackett SF, Ozaki H, Strauss RW, et al. Angiopoietin 2 expression in the retina: Upregulation during physiologic and pathologic neovascularization. J Cell Physiol 2000, 184:275-284.
88. Haga P, Ek J, Kran S Plasma tocopherol levels and vitamin E/beta-lipoprotein relationships during pregnancy and in cord blood. Am J Clin Nutr 1982, 36:1200-1204.
89. Halliday HL, Ehrenkranz RA Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2 2001.
90. Hammer ME, Mullen PW, Ferguson JG, et al. Logistic analysis of risk factors in acute retinopathy of prematurity. Am J Ophthalmol 1986, 102:1-6.
91. Hangai M, Miyamoto K, Hiroi K, et al. Roles of constitutive nitric oxide synthase in postischemic rat retina. Invest Ophthalmol Vis Sci 1999, 40:450-458.
92. Hardy P, Dumont I, Bhattacharya M, et al. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: A basis for ischemic retinopathy. Cardiovasc Res 2000, 47:489-509.
93. Hardy RJ, Palmer EA, Schaffer DB, et al. Outcome-based management of retinopathy of prematurity. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group. J Aapos 1997, 1:46-54.
94. Hayman M, Harvey AS, Hopkins IJ, et al. Paroxysmal tonic upgaze: A reappraisal of outcome. AnnNeurol 1998, 43:514-520.
95. Hertle RW, Dell'Osso LF Clinical and ocular motor analysis of congenital nystagmus in infancy. J Aapos 1999, 3:70-79.
96. Hesse L, Eberl W, Schlaud M, et al. Blood transfusion: Iron load and retinopathy of prematurity. Eur J Pediatr 1997, 156:465-470.
97. Higgins RD, Mendelsohn AL, DeFeo MJ, et al. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 1998, 116:601-605.
98. Hittner HM, Godio LB, Rudolph AJ, et al. Retrolental fibroplasia: Efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med 1981, 305:1365-1371.
99. Holmes JM, Leske DA, Zhang S The effect of raised inspired carbon dioxide on normal retinal vascular development in the neonatal rat. Curr Eye Res 1997, 16:78-81.
100. Holmes JM, Zhang S, Leske DA, et al. Metabolic acidosis-induced retinopathy in the neonatal rat. Invest Ophthalmol Vis Sci 1999, 40:804-809.
101. Holmstrom G, el Azazi M, Kugelberg U Ophthalmological follow up of preterm infants: A population based, prospective study of visual acuity and strabismus. Br J Ophthalmol 1999, 83:143-150.
102. Hoyt CS, Mousel DK, Weber AA Transient supranuclear disturbances of gaze in healthy neonates. Am J Ophthalmol 1980, 89:708-713.
103. Hughes S, Yang H, Chan-Ling T Vascularization of the human fetal retina: Roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 2000, 41:1217-1228.
104. Hunter DG, Mukai S Retinopathy of prematurity: Pathogenesis, diagnosis, and treatment. Int Ophthalmol Clin 1992, 32:163-184.
105. Hussain N, Clive J, Bhandari V Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics 1999, 104:e26.
106. Inder TE, Clemett RS, Austin NC, et al. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr 1997, 131:541-544.
107. Ishida S, Shinoda K, Kawashima S, et al. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2000, 41:1649-1656.
108. Iverson DA, Trese MT, Orgel IK, et al. Laser photocoagulation for threshold retinopathy of prematurity. Arch Ophthalmol 1991, 109:1342-1343.
109. Jacobson LK, Dutton GN Periventricular leukomalacia: An important cause of visual and ocular motility dysfunction in children. Surv Ophthalmol 2000, 45:1-13.
110. Jacobson L, Lundin S, Flodmark O, et al. Periventricular leukomalacia causes visual impairment in preterm children. A study on the aetiologies of visual impairment in a population-based group of preterm children born 1989-95 in the county of Varmland, Sweden. Acta Ophthalmol Scand 1998, 76:593-598.
111. James S, Lanman JT History of oxygen therapy and retrolental fibroplasia. Prepared by the American Academy of Pediatrics, Committee on Fetus and Newborn with the collaboration of special consultants. Pediatrics 1976, 57:591-642.
112. Jay M, Cowell J, Hungerford J Register of retinoblastoma: Preliminary results. Eye 1988, 2:102-105.
113. Johns KJ, Johns JA, Feman SS, et al. Retinopathy of prematurity in infants with cyanotic congenital heart disease. Am J Dis Child 1991, 145:200-203.
114. Johnson L, Bowen FW, Abbasi S, et al. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less. Pediatrics 1985, 75:619-638.
115. Kalina RE, Hodson WA, Morgan BC Retrolental fibroplasia in a cyanotic infant. Pediatrics 1972, 50:765-768.
116. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor: An endothelial cell mitogen related to PDGF. Science 1989, 246:1309-1312.
117. Keith CG, Doyle LW Retinopathy of prematurity in extremely low birth weight infants. Pediatrics 1995, 95:42-45.
118. Kerrison JB, Arnould VJ, Barmada MM, et al. A gene for autosomal dominant congenital nystagmus localizes to 6p12. Genomics 1996, 33:523-526.
119. Kerrison JB, Vagefi MR, Barmada MM, et al. Congenital motor nystagmus linked to Xq26-q27. Am J Hum Genet 1999, 64:600-607.
120. 2 levels and retrolental fibroplasia: A report of the cooperative study. Pediatrics 1977, 60:655-668.
121. Kraushar MF, Harper RG, Sia CG Rentrolental fibroplasia in a full-term infant. Am J Ophthalmol 1975, 80:106-108.
122. Kretzer FL, Hittner HM Spindle cells and retinopathy of prematurity: Interpretations and predictions. Birth Defects 1988, 24:147-168.
123. Kushner BJ Strabismus and amblyopia associated with regressed retinopathy of prematurity. Arch Ophthalmol 1982, 100:256-261.
124. Lanman JT Retrolental fibroplasias and oxygen therapy. JAMA 1954, 155:223-226.
125. Laser therapy for retinopathy of prematurity. Arch Ophthalmol 1994, 112:154-156. Laser ROP Study Group.
126. Laws D, Shaw DE, Robinson J, et al. Retinopathy of prematurity: A prospective study: Review at six months. Eye 1992, 6:477-483.
127. Levy AP, Levy NS, Wegner S, et al. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995, 270:13333-13340.
128. Lonchampt M, Pennel L, Duhault J Hyperoxia/normoxia-driven retinal angiogenesis in mice: A role for angiotensin II. Invest Ophthalmol Vis Sci 2001, 42:429-432.
129. Lucey JF, Dangman B A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics 1984, 73:82-96.
130. Lukiw WJ, Gordon WC, Rogaev EI, et al. Presenilin-2 (PS2) expression upregulation in a model of retinopathy of prematurity and pathoangiogenesis. Neuroreport 2001, 12:53-57.
131. Mariani G, Cifuentes J, Carlo WA Randomized trial of permissive hypercapnia in preterm infants. Pediatrics 1999, 104:1082-1088.
132. Markowitz GD, Handler LF, Katowitz JA Congenital euryblepharon and nasolacrimal anomalies in a patient with Down syndrome. J Pediatr Ophthalmol Strabismus 1994, 31:330-331.
133. McCormick AQ Transient cataracts in premature infants: A new clinical entity. CanJ Ophthalmol 1968, 3:202-206.
134. McDonald AD Cerebral palsy in children of very low birth weight. Arch Dis Child 1963, 38:579-588.
135. McLead RE, McGregor ML, Bremer D, et al. The HOPE-ROP study group. Pediatr Res 2000, 47:2457a.
136. + retinopathy of prematurity. Ophthalmology 1991, 98:576-580.
137. Meneses PI, Hajjar KA, Berns KI, et al. Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model. Gene Ther 2001, 8:646-648.
138. Michael AJ, Pesin SR, Katz LJ, et al. Management of late-onset angle-closure glaucoma associated with retinopathy of prematurity. Ophthalmology 1991, 98:1093-1098.
139. Michaelson IC The mode of development of the vascular system of the retina: With some observation on its significance for certain diseases. Trans Ophthalmol UK 1948, 68:1347-1807.
140. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994, 145:574-584.
141. Mills MD STOP-ROP results suggest selective use of supplemental oxygen for prethreshold ROP. Arch Ophthalmol 2000, 118:1121-1122.
142. Mittal M, Dhanireddy R, Higgins RD Candida sepsis and association with retinopathy of prematurity. Pediatrics 1998, 101:654-657.
143. Mohney BG, Robertson DM Ancillary testing for metastasis in patients with newly diagnosed retinoblastoma. Am J Ophthalmol 1994, 118:707-711.
144. Moravski CJ, Kelly DJ, Cooper ME, et al. Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension 2000, 36:1099-1104.
145. Msall ME, Phelps DL, DiGaudio KM, et al. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics 2000, 106:998-1005.
146. Oh H, Takagi H, Otani A, et al. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci U S A 2002, 99:383-388.
147. Onwochei BC, Simon JW, Bateman JB, et al. Ocular colobomata. Surv Ophthalmol 2000, 45:175-194.
148. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
149. Ouvrier RA, Billson F Benign paroxysmal tonic upgaze of childhood. J ChildNeurol 1988, 3:177-180.
150. Owens WC, Owens EC Retrolental fibroplasias in premature infants. II. Studies on the prophylaxis of the disease: The use of alpha-tocopherol acetate. Am J Ophthalmol 1949, 32:1631-1637.
151. Ozaki H, Yu AY, Della N, et al. Hypoxia inducible factor-1α is increased in ischemic retina: Temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 1999, 40:182-189.
152. Pagon RA Ocular coloboma. Surv Ophthalmol 1981, 25:223-236.
153. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991, 98:1628-1640.
154. Papp A, Nemeth I, Pelle Z [Retrospective biochemical study of the preventive property of antioxidants in retinopathy of prematurity]. Orv Hetil 1993, 134:1021-1026.
155. Parks MM, Johnson DA, Reed GW Long-term visual results and complications in children with aphakia: A function of cataract type. Ophthalmology 1993, 100:826-840. discussion 840-1.
156. Patz A, Hoeck LE, De La Cruz E Studies on the effect of high oxygen administration in retrolental fibroplasias. I. Nursery observations. Am J Ophthalmol 1952, 35:1248-1252.
157. Paul TO, Shepherd R Congenital nasolacrimal duct obstruction: Natural history and the timing of optimal intervention. J Pediatr Ophthalmol Strabismus 1994, 31:362-367.
158. Pe'er J, Shweiki D, Itin A, et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995, 72:638-645.
159. Penn JS, Henry MM, Tolman BL Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res 1994, 36:724-731.
160. 2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci 1995, 36:2063-2070.
161. Penn JS, Rajaratnam VS, Collier RJ, et al. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2001, 42:283-290.
162. Phelps DL Myopia of prematurity. Br J Ophthalmol 1997, 81:1021.
163. Phelps DL Reduced severity of oxygen-induced retinopathy in kittens recovered in 28% oxygen. Pediatr Res 1988, 24:106-109.
164. Phelps DL, Rosenbaum AL Effects of marginal hypoxemia on recovery from oxygen-induced retinopathy in the kitten model. Pediatrics 1984, 73:1-6.
165. Phelps DL, Watts JL Early light reduction for preventing retinopathy of prematurity in very low birth weight infants. Cochrane Database Syst Rev 2 2000.
166. Pierce EA, Avery RL, Foley ED, et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 1995, 92:905-909.
167. Pierce EA, Foley ED, Smith LE Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996, 114:1219-1228.
168. Pollard ZF Secondary angle-closure glaucoma in cicatricial retrolental fibroplasia. Am J Ophthalmol 1980, 89:651-653.
169. Procianoy RS, Garcia-Prats JA, Hittner HM, et al. An association between retinopathy of prematurity and intraventricular hemorrhage in very low birth weight infants. Acta Paediatr Scand 1981, 70:473-477.
170. Quinn GE, Dobson V, Barr CC, et al. Visual acuity of eyes after vitrectomy for retinopathy of prematurity: Follow-up at 5 1/2 years. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1996, 103:595-600.
171. Quinn GE, Dobson V, Kivlin J, et al. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1998, 105:1292-1300.
172. Quinn GE, Dobson V, Repka MX, et al. Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1992, 99:329-340.
173. Raju TN, Langenberg P, Bhutani V, et al. Vitamin E prophylaxis to reduce retinopathy of prematurity: A reappraisal of published trials. J Pediatr 1997, 131:844-850.
174. Rao NA, Wu GS Oxygen free radicals and retinopathy of prematurity. Br J Ophthalmol 1996, 80:387.
175. Repka MX, Palmer EA, Tung B Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 2000, 118:645-649.
176. Repka MX, Summers CG, Palmer EA, et al. The incidence of ophthalmologic interventions in children with birth weights less than 1251 grams. Results through 5 1/2 years. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1998, 105:1621-1627.
177. Revised indications for the treatment of retinopathy of prematurity. Early treatment for ROP cooperative group. Arch Ophthalmol 2003, 121:1684-1696.
178. Reynolds JD, Hardy RJ, Kennedy KA, et al. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med 1998, 338:1572-1576.
179. Robinson GS, Pierce EA, Rook SL, et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A 1996, 93:4851-4856.
180. Robinson R, O'Keefe M Follow-up study on premature infants with and without retinopathy of prematurity. Br J Ophthalmol 1993, 77:91-94.
181. Roth DB, Morales D, Feuer WJ, et al. Screening for retinopathy of prematurity employing the Retcam 120: Sensitivity and specificity. Arch Ophthalmol 2001, 119:268-272.
182. Roy FH, Summitt RL, Hiatt RL, et al. Ocular manifestations of the Rubinstein-Taybi syndrome: Case report and review of the literature. Arch Ophthalmol 1968, 79:272-278.
183. Sacks LM, Schaffer DB, Anday EK, et al. Retrolental fibroplasia and blood transfusion in very low-birth-weight infants. Pediatrics 1981, 68:770-774.
184. Saunders RA, Donahue ML, Christmann LM, et al. Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1997, 115:604-608.
185. Schachter J Chlamydial infections [third of three parts]. N Engl J Med 1978, 298:540-549.
186. Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1993, 100:230-237.
187. Schor CM, Fusaro RE, Wilson N, et al. Prediction of early-onset esotropia from components of the infantile squint syndrome. Invest Ophthalmol Vis Sci 1997, 38:719-740.
188. Schulman JA, Shults WT, et al. Monocular vertical nystagmus as an initial sign of chiasmal glioma. Am J Ophthalmol 1979, 87:87-90.
189. Schwartz SD, Harrison SA, Ferrone PJ, et al. Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 2000, 107:25-28.
190. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2001, 108:809-811.
191. Seiberth V, Linderkamp O Risk factors in retinopathy of prematurity: A multivariate statistical analysis. Ophthalmologica 2000, 214:131-135.
192. Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
193. Shafiee A, Penn JS, Krutzsch HC, et al. Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. Invest Ophthalmol Vis Sci 2000, 41:2378-2388.
194. Shih S, Ju M, Liu N, Smith L Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest 2003, 112:150-157.
195. Shohat M, Reisner SH, Krikler R, et al. Retinopathy of prematurity: Incidence and risk factors. Pediatrics 1983, 72:159-163.
196. Skoczenski AM, Norcia AM Development of VEP Vernier acuity and grating acuity in human infants. Invest Ophthalmol Vis Sci 1999, 40:2411-2417.
197. Slobody LB, Wasserman WE Survey of Clinical Pediatrics 1963, 160. McGraw-Hill, New York.
198. Smith LE, Kopchick JJ, Chen W, et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997, 276:1706-1709.
199. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111.
200. Stefani FH, Ehalt H Non-oxygen induced retinitis proliferans and retinal detachment in full-term infants. Br J Ophthalmol 1974, 58:490-513.
201. Steinkuller PG, Du L, Gilbert C, et al. Childhood blindness. J Aapos 1999, 3:26-32.
202. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995, 15:4738-4747.
203. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP): A randomized, controlled trial. I: Primary outcomes. Pediatrics 2000, 105:295-310. STOP-ROP Multicenter Study Group.
204. Strodtbeck F Assessment and management of ophthalmic disorders. Comprehensive Neonatal Nursing: A Physiologic Perspective 1998, 703-712. WB Saunders, Philadelphia. 2nd ed. C. Kenner, J.W. Lott, A. Flandermeyer (Eds.).
205. Subhani M, Combs A, Weber P, et al. Screening guidelines for retinopathy of prematurity: The need for revision in extremely low birth weight infants. Pediatrics 2001, 107:656-659.
206. Sullivan JL Iron, plasma antioxidants, and the "oxygen radical disease of prematurity". Am J Dis Child 1988, 142:1341-1344.
207. Szewczyk TS Retrolental fibroplasias and related ocular disease: Classification, etiology and prophylaxis. Am J Ophthalmology 1953, 36:1336-1361.
208. Terry TL Extreme prematurity and fibroplastic overgrowth of persistent vascular sheath behind each crystalline lens. Am J Ophthalmol 1942, 24:203-204.
209. Terry TL Fibroplastic overgrowth of persistent tunica vasculosa lentis in premature infants: II. Report of cases clinical aspects. Arch Ophthalmol 1943, 29:36-53.
210. Tin W, Milligan DW, Pennefather P, et al. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001, 84:F106-F110.
211. Tompkins C A sudden rise in the prevalence of retinopathy of prematurity blindness?. Pediatrics 2001, 108:526.
212. Vohr BR, Msall ME Neuropsychological and functional outcomes of very low birth weight infants. Semin Perinatol 1997, 21:202-220.
213. Wirth MG, Russell-Eggitt IM, Craig JE, et al. Aetiology of congenital and paediatric cataract in an Australian population. Br J Ophthalmol 2002, 86:782-786.
214. Wright K, Anderson ME, Walker E, et al. Should fewer premature infants be screened for retinopathy of prematurity in the managed care era?. Pediatrics 1998, 102:31-34.
215. Yen KG, Hess D, Burke B, et al. The optimum time to employ telephotoscreening to detect retinopathy of prematurity. Trans Am Ophthalmol Soc 2000, 98:145-150.
216. Yoshida A, Yoshida S, Ishibashi T, et al. Intraocular neovascularization. Histol Histopathol 1999, 14:1287-1294.
217. Yossuck P, Yan Y, Tadesse M, et al. Dexamethasone and critical effect of timing on retinopathy. Invest Ophthalmol Vis Sci 2000, 41:3095-3099.
218. Zanoni D, Isenberg SJ, Apt L A comparison of silver nitrate with erythromycin for prophylaxis against ophthalmia neonatorum. Clin Pediatr (Phila) 1992, 31:295-298.